Our T2 Insulin Insights is a semi-annual Research Service that explores the lived experience of people with type 2 diabetes who take insulin.
We asked patients about using—and endocrinologists about prescribing—a connected insulin pen.
Our second COVID-19 impact survey of 4,500+ U.S. diabetes patients found ongoing drug/supply delays, care disruptions, and declines in diet and exercise.
